Cardinal Health, Inc. CAH
220.22
(2.40)
(1.08%)
as of 25 Sep
- Market cap
- $51.6B
- P/E
- 30.3×
Follow CAH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Cardinal Health, Inc. (CAH) Free cash flow
Cardinal Health, Inc.'s free cash flow for fiscal 2026 was $4.6B, up 145.9% from $1.9B in fiscal 2025. Over the past ten years it has ranged from $797.0M (fiscal 2017) to $4.6B (fiscal 2026) — the current reading is the highest in ten years. Cardinal Health, Inc. ranks 2nd of 11 Medical Distribution companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2026 | $4.6B | 145.87% |
| FY2025 | $1.9B | (43.21%) |
| FY2024 | $3.3B | 38.09% |
| FY2023 | $2.4B | (16.18%) |
| FY2022 | $2.8B | 38.94% |
| FY2021 | $2.0B | 27.85% |
| FY2020 | $1.6B | (33.71%) |
| FY2019 | $2.4B | 0.42% |
| FY2018 | $2.4B | 199.12% |
| FY2017 | $797.0M | (68.20%) |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $1.4B | (14.85%) |
| Mar 2026 | $1.7B | 186.18% |
| Dec 2025 | $586.0M | (32.25%) |
| Sep 2025 | $865.0M | (32.84%) |
| 42 more quarters | Free account |
Against its own ten years
Low $797.0M
High $4.6B
Ten-year median
$2.4B
Current reading's percentile
100
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| MCK McKesson Corporation compare | $6.1B |
| CAH Cardinal Health, Inc. | $4.6B |
| COR Cencora, Inc. compare | $4.1B |
| HSIC Henry Schein, Inc. compare | $569.0M |
| YI 111, Inc. Sponsored ADR compare | −$11.8M |
| COSM Cosmos Health Inc. compare | −$12.5M |
| FOCL FocalTherics compare | −$19.1M |
| AHG Akso Health Group Sponsored ADR compare | −$182.5M |
| ACH Accendra Health, Inc. compare | −$210.9M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on CAH
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement